-
The p53 tumor suppressor protein, a modulator of cell proliferation.
J Biol Chem. 1992 Aug 5;267(22):15259-62
PMID: 1639769
-
Cancer. p53, guardian of the genome.
Nature. 1992 Jul 2;358(6381):15-6
PMID: 1614522
-
Cell cycle regulation and the p53 tumor suppressor protein.
Crit Rev Eukaryot Gene Expr. 1992;2(3):251-63
PMID: 1511188
-
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
Genes Dev. 1992 Oct;6(10):1874-85
PMID: 1398067
-
Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.
Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9210-4
PMID: 1409626
-
Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells.
Cell. 1992 Nov 13;71(4):543-6
PMID: 1423612
-
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.
Cell. 1992 Nov 13;71(4):587-97
PMID: 1423616
-
Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression.
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10415-9
PMID: 1438227
-
G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.
J Biol Chem. 1993 Apr 15;268(11):8298-308
PMID: 8463339
-
Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.
Oncogene. 1993 Jun;8(6):1519-28
PMID: 8502477
-
Functional domains of the human B-myb gene product.
J Biol Chem. 1993 Jul 5;268(19):14161-7
PMID: 8314782
-
An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription.
EMBO J. 1993 Jul;12(7):2705-13
PMID: 8334989
-
The tumor suppressor p53.
Biochim Biophys Acta. 1993 Aug 23;1155(2):181-205
PMID: 8357826
-
Clinical implications of the p53 tumor-suppressor gene.
N Engl J Med. 1993 Oct 28;329(18):1318-27
PMID: 8413413
-
Cell cycle effects of microinjected antisense oligodeoxynucleotides to p34cdc2 kinase.
Ann N Y Acad Sci. 1992 Oct 28;660:209-18
PMID: 1340123
-
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Cell. 1993 Nov 19;75(4):805-16
PMID: 8242751
-
WAF1, a potential mediator of p53 tumor suppression.
Cell. 1993 Nov 19;75(4):817-25
PMID: 8242752
-
Braking the cycle.
Cell. 1993 Dec 3;75(5):839-41
PMID: 8252620
-
Cell cycle-specific association of E2F with the p130 E1A-binding protein.
Genes Dev. 1993 Dec;7(12A):2392-404
PMID: 8253385
-
HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.
EMBO J. 1994 Feb 15;13(4):871-8
PMID: 8112300
-
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
Cancer Res. 1994 Mar 1;54(5):1169-74
PMID: 8118801
-
p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.
Cell. 1994 Mar 25;76(6):1013-23
PMID: 8137420
-
p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5320-4
PMID: 8202487
-
Gene transfer: DNA microinjection compared with DNA transfection with a very high efficiency.
Mol Cell Biol. 1982 Sep;2(9):1145-54
PMID: 6294505
-
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.
Anal Biochem. 1983 Jul 1;132(1):6-13
PMID: 6312838
-
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem. 1987 Apr;162(1):156-9
PMID: 2440339
-
Rearrangement of the p53 gene in human osteogenic sarcomas.
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7716-9
PMID: 2823272
-
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.
Science. 1989 Apr 14;244(4901):217-21
PMID: 2649981
-
DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB.
J Biol Chem. 1990 Jun 5;265(16):9280-4
PMID: 2160970
-
Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
Proc Natl Acad Sci U S A. 1990 Aug;87(16):6166-70
PMID: 2143581
-
p53 functions as a cell cycle control protein in osteosarcomas.
Mol Cell Biol. 1990 Nov;10(11):5772-81
PMID: 2233717
-
Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells.
Blood. 1991 Jan 1;77(1):149-58
PMID: 1984793
-
Constitutively expressed c-myb abrogates the requirement for insulinlike growth factor 1 in 3T3 fibroblasts.
Mol Cell Biol. 1991 Feb;11(2):731-6
PMID: 1990279
-
Growth regulated expression of B-myb in fibroblasts and hematopoietic cells.
J Cell Physiol. 1991 Sep;148(3):338-43
PMID: 1717494
-
Tumor suppressor genes.
Science. 1991 Nov 22;254(5035):1138-46
PMID: 1659741
-
Cyclin A is required at two points in the human cell cycle.
EMBO J. 1992 Mar;11(3):961-71
PMID: 1312467
-
B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines.
Blood. 1992 May 15;79(10):2708-16
PMID: 1586718
-
Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.
Oncogene. 1992 Jun;7(6):1233-40
PMID: 1594249
-
c-myb and growth control.
Crit Rev Eukaryot Gene Expr. 1992;2(3):225-35
PMID: 1511186